Reporting owner · CIK 0001913253

Guerrero Ramiro

Visual SEC Form 4 history across 1 companies, 7 transactions and 6 filings.

DIRMAIA Biotechnology, Inc.
Open-market mix
Filings6Form 4 records
Buying$265.8K4 purchases
Selling$00 sales
Net value$265.8KBuys minus sells
Companies14 securities
Most recentAug 24, 2026buy

Open-market buy performance

90-day forward return on this insider's open-market purchases

90d forward
Average return+6.7%Across 1 open-market buy
Median return+6.7%Half the buys outperformed this
How it's computed

For every open-market buy (Form 4 code P, acquisition A) in the selected window, we take the closing price on the transaction date and 90 calendar days later, then compute the percentage change. The figures shown are the simple average and median of those per-buy returns.

  • Window follows the rest of the summary (all-history or last 3 months).
  • Only buys with a resolved price context are counted.
  • Includes both positive and negative outcomes; gains and losses net out at the per-buy level.

Monthly open-market activity

Reported purchase and sale transaction counts

Buys Sells
530-3-5Dec 23Dec 242Feb 25Dec 252Aug 26

Net value flow

Buys minus sells

Dec 23
$0
Dec 24
$0
Feb 25
$247.1K
Dec 25
$0
Aug 26
$18.7K

Transaction texture

Ownership and ticket size

Average P/S size$66.5K
Median P/S size$63.2K
Direct7
Indirect0
Aug 24, 2026buy

Latest Form 4 facts

Quick context from source filings

Latest transaction

buy at MAIA Biotechnology, Inc. on Aug 24, 2026 valued at $2,386.

Review SEC filing
Latest buy

buy at MAIA Biotechnology, Inc. on Aug 24, 2026 valued at $2,386.

Review SEC filing
Latest sale

No open-market insider sale is available.

Associated companies

Visual map of known reporting history

Guerrero Ramiro Insider Activity FAQ

SEC Form 4 context

Who is Guerrero Ramiro?

Guerrero Ramiro is a reporting owner in SEC Form 4 filings with reporting owner CIK 0001913253.

Which companies has Guerrero Ramiro reported transactions for?

MAIA Biotechnology, Inc.

When was Guerrero Ramiro's latest insider buy?

buy at MAIA Biotechnology, Inc. on Aug 24, 2026 valued at $2,386.

When was Guerrero Ramiro's latest insider sale?

No open-market insider sale is available for this period.

Where can I see the original SEC filings?

Each transaction row links directly to the source SEC filing so the reported Form 4 details can be reviewed.

Are performance metrics included?

This version does not calculate win rates, forward returns, benchmark-adjusted returns, or high-conviction scores.